Declan Jones,
Neuroscience Therapeutic Area Lead
Declan N.C. Jones, PhD joined the newly established J&J London Innovation Centre in June 2013 as VP and Neuroscience Lead. The London Innovation Centre (http://www.jnjinnovation.com/) will build relationships with the academic institutions, biotech organizations and venture capital firms in the UK and will be a base for outreach throughout Europe. Declan is particular focused on identifying opportunities for the treatment for Alzheimer’s disease and mood disorders, including diagnostics and biomarkers. Prior to this role, Declan was Head of Research for GlaxoSmithKline’s Centre of Excellence for External Drug Discovery (CEEDD) after spending fourteen years in roles with increasing responsibility in CNS drug discovery within GlaxoSmithKline, finishing as Director of In Vivo Neurobiology and also Disease Area Strategy Leader for Schizophrenia and Bipolar Disorders.
|
|
|
